Dorian LPG
LPG
YETI Holdings
YETI
Teradata Corp
TDC
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
FENC Fennec Pharmaceuticals
- 6.550
- +0.230+3.64%
Trading Mar 18 11:01 ET
178.76MMarket Cap-2183.33P/E (TTM)
6.590High6.395Low76.93KVolume6.400Open6.320Pre Close500.46KTurnover0.55%Turnover RatioLossP/E (Static)27.29MShares11.37052wk High-32.43P/B92.33MFloat Cap3.96052wk Low--Dividend TTM14.10MShs Float14.986Historical High--Div YieldTTM3.09%Amplitude3.255Historical Low6.505Avg Price1Lot Size
About Fennec Pharmaceuticals Company
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Company Profile
SymbolFENC
Company NameFennec Pharmaceuticals
Listing DateSep 13, 2017
Founded1996
CEOMr. Jeffrey S. Hackman
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
AddressResearch Triangle Park,68 T.W. Alexander Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-636-4530
Websitehttp://www.fennecpharma.com
Company Executives
- Name
- Position
- Salary
- Jeffrey S. Hackman
- Chief Executive Officer and Director
- --
- Robert Andrade
- Chief Financial Officer and Principal Accounting Officer
- 1.31M
- Christiana Cioffi, M.B.A.
- Chief Strategy Officer
- --
- Terry Evans
- Chief Commercial Officer
- --
- Pierre S. Sayad, M.S.
- Chief Medical Officer
- --
- Dr. Khalid Islam, PhD
- Chairman of the Board
- 225.23K
- Rostislav Raykov
- Director
- 2.54M
- Chris A. Rallis
- Independent Director
- 173.18K
- Dr. Jodi A. Cook, PhD
- Independent Director
- 153.81K
- Dr. Marco M. Brughera
- Independent Director
- 166.31K